title: CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression.
abstract: The Coding Region Determinant-Binding Protein (CRD-BP) is an RRM and KH-domain-containing protein that recognizes specifically at least three RNAs. It binds to one of the two c-myc mRNA instability elements, to the 5'Un Translated Region (UTR) of the leader 3 IGF-II mRNA and to the oncofetal H19 RNA. CRD-BP has been assigned a role in stabilizing c-myc mRNA by preventing its endonucleolytic cleavage and in repressing the translation of the leader 3 IGF-II mRNA, the major embryonic species of this message. CRD-BP is normally expressed only in fetal tissues. However, its expression is detected in primary tumors and transformed cell lines of different origins. The vast majority of colon (80%) and breast (60%) tumors and sarcomas (73%) express CRD-BP whereas in other tumor types, for example prostate carcinomas, its expression is rare. CRD-BP expression has also been detected in benign tumors such as breast fibroadenomas, meningiomas and other benign mesenchymal tumors, implying a role for this gene in abnormal cell proliferation. In breast carcinomas, CRD-BP expression and or gene copy number gains in the region encompassing the c-myc locus were detected in approximately 75% of tumors, implying that the deregulated expression of c-myc may be more widespread than previously believed. Infiltrated lymph nodes, corresponding to CRD-BP-positive primary tumors, were also found positive indicating that monitoring for CRD-BP could prove useful for the detection and monitoring of disseminated disease.
authors.affiliation: Department of Genetics, St Savvas Hospital, Athens, Greece. pioannidis@ath.forthnet.gr
authors.forename: P
authors.initials: P
authors.lastname: Ioannidis
authors.forename: L
authors.initials: L
authors.lastname: Mahaira
authors.forename: A
authors.initials: A
authors.lastname: Papadopoulou
authors.forename: M R
authors.initials: MR
authors.lastname: Teixeira
authors.forename: S
authors.initials: S
authors.lastname: Heim
authors.forename: J A
authors.initials: JA
authors.lastname: Andersen
authors.forename: E
authors.initials: E
authors.lastname: Evangelou
authors.forename: U
authors.initials: U
authors.lastname: Dafni
authors.forename: N
authors.initials: N
authors.lastname: Pandis
authors.forename: T
authors.initials: T
authors.lastname: Trangas
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D018507:Gene Expression Regulation, Developmental; D006801:Humans; D009369:Neoplasms / Q000235:genetics / Q000378:metabolism; D016271:Proto-Oncogene Proteins c-myc / Q000096:biosynthesis / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism*; D016601:RNA-Binding Proteins / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*
chemical_list: D000951:Antigens, Neoplasm; C406144:IGF2BP1 protein, human; D016271:Proto-Oncogene Proteins c-myc; D012333:RNA, Messenger; D016601:RNA-Binding Proteins; C031192:oncofetal antigens